Lapatinib Impurity 7;231278-83-4
WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com
Product Number: L079007
English Name: Lapatinib Impurity 7
English Alias: 5-(4-((4-(benzyloxy)-3-chlorophenyl)amino)quinazolin-6-yl)furan-2-carbaldehyde
CAS Number: 231278-83-4
Molecular Formula: C₂₆H₁₈ClN₃O₃
Molecular Weight: 455.89
Product Advantages: Lapatinib Impurity 7 has high purity and good chemical stability. Its structure is confirmed by precise spectroscopic analysis (such as nuclear magnetic resonance and mass spectrometry), and it remains stable and uniform under different experimental conditions. As a reference substance, its precision ensures the accuracy and repeatability of Lapatinib impurity detection results, providing a reliable basis for pharmaceutical quality control and facilitating quality research in the drug research and development and production processes.
Application Fields:
Quality Control: As an impurity reference standard, it is used to establish and validate the detection methods for impurities in Lapatinib bulk drugs and formulations, ensuring the sensitivity and specificity of the detection methods to meet pharmaceutical quality standards.
Process Optimization: During the production of Lapatinib, by monitoring the content of this impurity and analyzing the stages of its generation, it assists in optimizing the synthesis process, reducing impurity formation, and improving product quality.
Stability Studies: In drug stability tests, it analyzes the changes of this impurity under different storage conditions, providing data support for determining the shelf life and storage conditions of drugs.
Background Description: Lapatinib is an important targeted drug for the treatment of HER2-positive breast cancer. In the process of its research, development, production, and quality control, impurity research is a key link to ensure drug safety and effectiveness. The presence of impurities may affect the drug's efficacy and even bring potential toxic and side effects. As a related impurity of Lapatinib, in-depth research on Lapatinib Impurity 7 helps to comprehensively evaluate the quality of Lapatinib drugs and ensure the safety of clinical medication.
Research Status: Currently, research on Lapatinib Impurity 7 mainly focuses on detection technology and impurity generation mechanisms. In terms of detection technology, advanced methods such as Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry (UPLC-MS/MS) and high-resolution mass spectrometry are constantly being explored to achieve precise detection of trace impurities. In the study of impurity generation mechanisms, the causes and influencing factors of its formation are analyzed by simulating drug synthesis reactions and storage environments, providing a theoretical basis for controlling impurities from the source. In addition, research on the impact of this impurity on the efficacy and safety of Lapatinib is also gradually being carried out
NOTE！
We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS.
This product is intended for laboratory use only!
WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com
NEW IN STOCK!
The Molcoo Laboratory added drug impurity reference standards, including Baricitinib, Piperazine, Benzylpenicillin, Tranilast and multiple N-Nitroso drug impurities! Now available for immediate delivery!
China